Abstract
Despite the disproportionate underuse of genetic counseling and testing for BRCA1/2 (BRCA)-associated hereditary breast and ovarian cancer (HBOC) risk among Latinas, little is known about the associated barriers and facilitators. We conducted in-depth qualitative interviews with 20 at-risk Latina women from diverse backgrounds. Eligible women were diagnosed with breast cancer <50 years, with or without a family history of breast and/or ovarian cancer (>1 first-degree relative diagnosed <50 years). All interviews were conducted in Spanish, audio recorded, transcribed, and translated into English. Two bilingual coders used thematic analyses to identify 7 main themes. Results revealed very low levels of awareness and knowledge about HBOC and BRCA genetic counseling. Interestingly, for most Latinas, competing life demands and cultural concerns (fatalismo and destino) did not strongly influence personal beliefs about genetic counseling. In addition, older women were equally as interested in education, cancer prevention, and BRCA genetic counseling as younger women. These findings suggest that Latinas, regardless of age, increasingly acknowledge and prioritize their own health. Women reported their main motivator to undergo counseling was concern about family members’ cancer risks. Main barriers included financial and insurance concerns, and lack of awareness about genetic services. Investigating the beliefs and attitudes of diverse populations of Latinas at risk for HBOC reveals logistical barriers to BRCA genetic counseling uptake within this under-represented community. Efforts are needed to provide at-risk Latina breast cancer survivors’ knowledge of and access to genetic counseling and testing based on risk status and Latinas’ increasing responsiveness and uptake of these services.
Similar content being viewed by others
References
Affordable Care Act Implementation FAQs - Set 12. Retrieved March 26, 2016, from https://www.cms.gov/CCIIO/Resources/Fact-Sheets-and-FAQs/aca_implementation_faqs12.html.
American Cancer Society (2015). Cancer facts & figures for Hispanics/Latinos 2015–2017. Atlanta: American Cancer Society. Retrieved February 24, 2017, from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-hispanics-and-latinos/cancer-facts-and-figures-for-hispanics-and-latinos-2015-2017.pdf.
American Society of Clinical Oncology. (2015). American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 33(31), 3660–3667.
Anderson, B., McLosky, J., Wasilevich, E., Lyon-Callo, S., Duquette, D., & Copeland, G. (2012). Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors. Journal of Cancer Epidemiology. doi:10.1155/2012/298745.
Banegas, M. P., & Li, C. I. (2012). Breast cancer characteristics and outcomes among hispanic black and hispanic white women. Breast Cancer Research and Treatment, 134(3), 1297–1304.
Banegas, M. P., Tao, L., Altekruse, S., Anderson, W. F., John, E. M., Clarke, C. A., & Gomez, S. L. (2014). Heterogeneity of breast cancer subtypes and survival among hispanic women with invasive breast cancer in california. Breast Cancer Research and Treatment, 144(3), 625–634.
Brain, K., Gray, J., Norman, P., Parsons, E., Clarke, A., Rogers, C., et al. (2000). Why do women attend familial breast cancer clinics? Journal of Medical Genetics, 37(3), 197–202.
Chen, L., & Li, C. I. (2015). Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 24(11), 1666–1672.
Crouch, M., & McKenzie, H. (2006). The logic of small samples in interview-based qualitative research. Social Science Information, 45(4), 483–499.
Dean, M., Boland, J., Yeager, M., Im, K. M., Garland, L., Rodriguez-Herrera, M., et al. (2015). Addressing health disparities in hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2. Gigascience, 4(1), 50.
Doksum, T., Bernhardt, B. A., & Holtzman, N. A. (2003). Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing? Genetics in Medicine, 5(2), 99–105.
Domchek, S. M., Friebel, T. M., Singer, C. F., Evans, D. G., Lynch, H. T., Isaacs, C., et al. (2010). Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA, 304(9), 967–975.
Dunnwald, L. K., Rossing, M. A., & Li, C. I. (2007). Hormone receptor status, tumor characteristics, and prognosis: A prospective cohort of breast cancer patients. Breast Cancer Research, 9(1), 1.
Escher, M., & Sappino, A. P. (2000). Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO, 11(9), 1131–1135.
Gammon, A. D., Rothwell, E., Simmons, R., Lowery, J. T., Ballinger, L., Hill, D. A., et al. (2011). Awareness and preferences regarding BRCA1/2 genetic counseling and testing among latinas and non-latina white women at increased risk for hereditary breast and ovarian cancer. Journal of Genetic Counseling, 20(6), 625–638.
Giacomini, M. K., Cook, D. J., & Evidence-Based Medicine Working Group. (2000a). Users' guides to the medical literature: XXIII. Qualitative research in health care A. Are the results of the study valid? JAMA, 284(3), 357–362.
Giacomini, M. K., Cook, D. J., & Evidence-Based Medicine Working Group. (2000b). Users' guides to the medical literature: XXIII. Qualitative research in health CareB. What are the results and how do they help me care for my patients? JAMA, 284(4), 478–482.
Heck, J. E., Franco, R., Jurkowski, J. M., & Sheinfeld Gorin, S. (2008). Awareness of genetic testing for cancer among united states hispanics: The role of acculturation. Community Genetics, 11(1), 36–42. doi:10.1159/000111638.
Herrinton, L. J., Barlow, W. E., Yu, O., Geiger, A. M., Elmore, J. G., Barton, M. B., et al. (2005). Efficacy of prophylactic mastectomy in women with unilateral breast cancer: A cancer research network project. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 23(19), 4275–4286.
John, E. M., Miron, A., Gong, G., Phipps, A. I., Felberg, A., Li, F. P., et al. (2007). Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA, 298(24), 2869–2876.
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., et al. (2002). Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. New England Journal of Medicine, 346(21), 1609–1615.
Kinney, A. Y., Gammon, A., Coxworth, J., Simonsen, S. E., & Arce-Laretta, M. (2010). Exploring attitudes, beliefs, and communication preferences of latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genetics in Medicine, 12(2), 105–115.
Lagos-Jaramillo, V. I., Press, M. F., Ricker, C. N., Dubeau, L., Mai, P. L., & Weitzel, J. N. (2011). Pathological characteristics of BRCA-associated breast cancers in hispanics. Breast Cancer Research and Treatment, 130(1), 281–289.
Lantz, P. M., Mujahid, M., Schwartz, K., Janz, N. K., Fagerlin, A., Salem, B., et al. (2006). The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. American Journal of Public Health, 96(12), 2173–2178.
Lara-Medina, F., Pérez-Sánchez, V., Saavedra-Pérez, D., Blake-Cerda, M., Arce, C., Motola-Kuba, D., et al. (2011). Triple-negative breast cancer in hispanic patients. Cancer, 117(16), 3658–3669.
Levy, D. E., Byfield, S. D., Comstock, C. B., Garber, J. E., Syngal, S., Crown, W. H., et al. (2011). Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and hispanic women particularly at risk. Genetics in Medicine, 13(4), 349–355.
Lynce, F., Graves, K. D., Jandorf, L., Ricker, C., Castro, E., Moreno, L., et al. (2016). Genomic disparities in breast cancer among latinas. Cancer Control : Journal of the Moffitt Cancer Center, 23(4), 359–372.
Mai, P. L., Vadaparampil, S. T., Breen, N., McNeel, T. S., Wideroff, L., & Graubard, B. I. (2014). Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 national health interview surveys. American Journal of Preventive Medicine, 46(5), 440–448.
McDonnell, S. K., Schaid, D. J., Myers, J. L., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001). Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 19(19), 3938–3943.
Miedema, B., & Easley, J. (2012). Barriers to rehabilitative care for young breast cancer survivors: A qualitative understanding. Supportive Care in Cancer, 20(6), 1193–1201.
National Comprehensive Cancer Network (2017). Clinical practice guidelines in oncology. Genetic/familial high-risk assessment: breast and ovarian. V.2.2017. Retrieved January 29, 2017, from https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf.
Nelson, H. D., Huffman, L. H., Fu, R., & Harris, E. L. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the US preventive services task force. Annals of Internal Medicine, 143(5), 362–379.
Ooi, S. L., Martinez, M. E., & Li, C. I. (2011). Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Research and Treatment, 127(3), 729–738.
Pagán, J. A., Su, D., Li, L., Armstrong, K., & Asch, D. A. (2009). Racial and ethnic disparities in awareness of genetic testing for cancer risk. American Journal of Preventive Medicine, 37(6), 524–530.
Penchaszadeh, V. B. (2001). Genetic counseling issues in latinos. Genetic Testing, 5(3), 193–200.
Pérez-Stable, E. J., Sabogal, F., Otero-Sabogal, R., Hiatt, R. A., & McPhee, S. J. (1992). Misconceptions about cancer among latinos and anglos. JAMA, 268(22), 3219–3223.
Pope, C., Ziebland, S., & Mays, N. (2000). Qualitative research in health care. analysing qualitative data. BMJ (Clinical Research Ed.), 320(7227), 114–116.
Powe, B. D., & Finnie, R. (2003). Cancer fatalism: the state of the science. Cancer Nursing, 26(6), 454–465 quiz 466-7.
Pronzato, P., Mustacchi, G., De Matteis, A., Di Costanzo, F., Rulli, E., Floriani, I., et al. (2011). Biological characteristics and medical treatment of breast cancer in young women-a featured population: results from the NORA study. International Journal of Breast Cancer, 2011, 534256.
Quinn, G. P., McIntyre, J., & Vadaparampil, S. T. (2011). Preferences for hereditary breast and ovarian cancer information among mexican, cuban and puerto rican women at risk. Public Health Genomics, 14(4–5), 248–258.
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., Van't Veer, L., Garber, J. E., et al. (2002). Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. New England Journal of Medicine, 346(21), 1616–1622.
Ricker, C., Lagos, V., Feldman, N., Hiyama, S., Fuentes, S., Kumar, V., et al. (2006). If we build it… will they come?–establishing a cancer genetics services clinic for an underserved predominantly latina cohort. Journal of Genetic Counseling, 15(6), 505–514.
Scherr, C. L., Vasquez, E., Quinn, G. P., & Vadaparampil, S. T. (2014). Genetic counseling for hereditary breast and ovarian cancer among puerto rican women living in the united states. Reviews on Recent Clinical Trials, 9(4), 245–253.
Schwartz, M. D., Isaacs, C., Graves, K. D., Poggi, E., Peshkin, B. N., Gell, C., et al. (2012). Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancer, 118(2), 510–517.
Stewart, S. L., Kaplan, C. P., Lee, R., Joseph, G., Karliner, L., Livaudais-Toman, J., & Pasick, R. J. (2016). Validation of an efficient screening tool to identify low-income women at high risk for hereditary breast cancer. Public Health Genomics, 19(6), 342–351.
Sussner, K. M., Thompson, H. S., Valdimarsdottir, H. B., Redd, W. H., & Jandorf, L. (2009). Acculturation and familiarity with, attitudes towards and beliefs about genetic testing for cancer risk within Latinas in East Harlem, New York City. Journal of Genetic Counseling, 18(1), 60–71.
Sussner, K. M., Edwards, T., Villagra, C., Rodriguez, M. C., Thompson, H. S., Jandorf, L., et al. (2015). BRCA genetic counseling among at-risk latinas in new york city: new beliefs shape new generation. Journal of Genetic Counseling, 24(1), 134–148.
Sussner, K. M., Jandorf, L., Thompson, H. S., & Valdimarsdottir, H. B. (2010). Interest and beliefs about BRCA genetic counseling among at-risk latinas in new york city. Journal of Genetic Counseling, 19(3), 255–268.
Sussner, K. M., Jandorf, L., Thompson, H. S., & Valdimarsdottir, H. B. (2013). Barriers and facilitators to BRCA genetic counseling among at-risk latinas in new york city. Psycho-Oncology, 22(7), 1594–1604.
Thompson, H. S., Valdimarsdottir, H. B., Jandorf, L., & Redd, W. (2003). Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: Differences across African American, Latina and Caucasian women. Patient Education and Counseling, 51(3), 217–227.
U.S. Preventive Services Task Force (2013). Recommendation summary. BRCA-related cancer: risk assessment, genetic counseling, and genetic testing. December 2013. Retrieved May 12, 2015, from http://www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/brca-related-cancer-risk-assessmentgenetic-counseling-and-genetic-testing.
United States Census Bureau (2010). The hispanic population. Retrieved Feb 6, 2017 from http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf.
United States Census Bureau (2015) Projections of the size and composition of the U.S. population: 2014 to 2060. Retrieved July 28, 2016, from https://www.census.gov/content/dam/Census/library/publications/2015/demo/p25-1143.pdf.
Vadaparampil, S. T., McIntyre, J., & Quinn, G. P. (2010a). Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk hispanic women: Similarities and variations by sub-ethnicity. Journal of Genetic Counseling, 19(6), 618–629.
Vadaparampil, S. T., Quinn, G. P., Small, B. J., McIntyre, J., Loi, C. A., Closser, Z., & Gwede, C. K. (2010b). A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of hispanic women with a personal or family history of cancer. Genetic Testing and Molecular Biomarkers, 14(1), 99–106.
Vadaparampil, S. T., Wideroff, L., Breen, N., & Trapido, E. (2006). The impact of acculturation on awareness of genetic testing for increased cancer risk among hispanics in the year 2000 national health interview survey. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 15(4), 618–623.
Van Sprundel, T., Schmidt, M., Rookus, M., Brohet, R., Van Asperen, C., Rutgers, E. T., et al. (2005). Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. British Journal of Cancer, 93(3), 287–292.
Watlington, A. T., Byers, T., Mouchawar, J., Sauaia, A., & Ellis, J. (2007). Does having insurance affect differences in clinical presentation between hispanic and non-Hispanic white women with breast cancer? Cancer, 109(10), 2093–2099.
Weitzel, J. N., Clague, J., Martir-Negron, A., Ogaz, R., Herzog, J., Ricker, C., et al. (2013). Prevalence and type of BRCA mutations in hispanics undergoing genetic cancer risk assessment in the southwestern united states: a report from the clinical cancer genetics community research network. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 31(2), 210–216.
Wideroff, L., Vadaparampil, S. T., Greene, M. H., Taplin, S., Olson, L., & Freedman, A. N. (2005). Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. Journal of Medical Genetics, 42(10), 749–755.
Acknowledgements
The authors would like to acknowledge the contribution of Nueva Vida, Inc. for their assistance in recruitment, as well as the women who participated in the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Ms. Rajpal, Ms. Munoz, Ms. Peshkin, and Dr. Graves declare that they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
Animal Studies
No animal studies were carried out by the authors for this article.
Rights and permissions
About this article
Cite this article
Rajpal, N., Muñoz, J., Peshkin, B.N. et al. Insights into BRCA1/2 Genetic Counseling from Ethnically Diverse Latina Breast Cancer Survivors. J Genet Counsel 26, 1221–1237 (2017). https://doi.org/10.1007/s10897-017-0096-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-017-0096-5